ZYUS Life Sciences Corporation
ZLSCF
$0.01
-$0.03-65.75%
OTC PK
| 09/30/2025 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.71% | 17.71% | -15.91% | -15.91% | 82.24% |
| Total Depreciation and Amortization | 7.43% | 7.43% | 1.03% | 1.03% | -14.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.11% | -31.11% | 20.52% | 20.52% | -97.18% |
| Change in Net Operating Assets | -104.12% | -104.12% | 1,280.78% | 1,280.78% | 96.58% |
| Cash from Operations | -29.81% | -29.81% | 28.52% | 28.52% | 47.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -135.91% | -135.91% | -- | -- | -- |
| Total Debt Issued | 24.65% | 24.65% | 9.20% | 9.20% | -65.00% |
| Total Debt Repaid | 43.82% | 43.82% | 43.67% | 43.67% | -829.41% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.57% | 28.57% | 18.71% | 18.71% | -68.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.22% | -91.22% | 91.29% | 91.29% | -177.66% |